Zobrazeno 1 - 6
of 6
pro vyhledávání: '"A R, Goudev"'
Autor:
Lars Wallentin, Claes Held, Paul W. Armstrong, Christopher P. Cannon, Richard Y. Davies, Christopher B. Granger, Emil Hagström, Robert A. Harrington, Judith S. Hochman, Wolfgang Koenig, Sue Krug‐Gourley, Emile R. Mohler, Agneta Siegbahn, Elizabeth Tarka, Philippe Gabriel Steg, Ralph A. H. Stewart, Robert Weiss, Ollie Östlund, Harvey D. White, Andrzej Budaj, Diego Ardissino, Alvaro Avezum, Philip E. Aylward, Alfonso Bryce, Hong Chen, Ming‐Fong Chen, Ramon Corbalan, Anthony J. Dalby, Nicolas Danchin, Robbert J. De Winter, Stefan Denchev, Rafael Diaz, Moses Elisaf, Marcus D. Flather, Assen R. Goudev, Liliana Grinfeld, Steen Husted, Hyo‐Soo Kim, Ales Linhart, Eva Lonn, José López‐Sendón, Athanasios J. Manolis, José C. Nicolau, Prem Pais, Alexander Parkhomenko, Terje R. Pedersen, Daniel Pella, Marco A. Ramos‐Corrales, Mikhail Ruda, Mátyás Sereg, Saulat Siddique, Peter Sinnaeve, Piyamitr Sritara, Henk P. Swart, Rody G. Sy, Tamio Teramoto, Hung‐Fat Tse, W. Douglas Weaver, Margus Viigimaa, Dragos Vinereanu, Junren Zhu
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 6 (2016)
BackgroundWe evaluated lipoprotein‐associated phospholipase A2 (Lp‐PLA2) activity in patients with stable coronary heart disease before and during treatment with darapladib, a selective Lp‐PLA2 inhibitor, in relation to outcomes and the effects
Externí odkaz:
https://doaj.org/article/43af20ec4c304e52a6da8a25a7ce73f4
Autor:
Scott D Solomon, Brian L Claggett, Zi Michael Miao, Rafael Diaz, G Michael Felker, John J V McMurray, Marco Metra, Ramon Corbalan, Gerasimos Filippatos, Assen R Goudev, Viatcheslav Mareev, Pranas Serpytis, Thomas Suter, Mehmet B Yilmaz, Faiez Zannad, Stuart Kupfer, Stephen B Heitner, Fady I Malik, John R Teerlink
Publikováno v:
European heart journal. 43(23)
Aims In GALACTIC-HF, the cardiac myosin activator omecamtiv mecarbil compared with placebo reduced the risk of heart failure events or cardiovascular death in patients with heart failure with reduced ejection fraction. We explored the influence of at
Autor:
Guy De Backer, Robert J. Petrella, Assen R. Goudev, Ghazi Ahmad Radaideh, Andrzej Rynkiewicz, Atul Pathak
Publikováno v:
International Journal of Hypertension, Vol 2013 (2013)
Background. High blood pressure is a substantial risk factor for cardiovascular disease. Design & Methods. The Physicians' Observational Work on patient Education according to their vascular Risk (POWER) survey was an open-label investigation of epro
Externí odkaz:
https://doaj.org/article/daa8f83888534ed08a9a9315d18279db
Autor:
Guy, De Backer, Robert J, Petrella, Assen R, Goudev, Ghazi A, Radaideh, Andrzej, Rynkiewicz, Atul, Pathak
Publikováno v:
Fundamentalclinical pharmacology. 27(2)
This article describes the design and methodology of the POWER study (Physicians' Observational Work on Patient Education According to their Vascular Risk). POWER is an open-label multinational postmarketing study of the angiotensin II-receptor block
Publikováno v:
MedGenMed : Medscape general medicine. 6(4)
Fifty-five postmenopausal women with menopausal complaints were treated with the food supplement Melbrosia for 3 months. Menopausal symptom evaluation scales and psychological questionnaires were administered, and cardiovascular disease markers in bl
Publikováno v:
General physiology and biophysics. 15(6)
The dynamics of binding of exogenous alpha-tocopherol (alpha-T) added to native or oxidatively modified LDLs (LDLs or oxLDLs) were investigated. Venous blood from 31 clinically healthy blood donors (15 males and 16 females) was used. LDLs were isolat